0000899243-20-018956.txt : 20200710 0000899243-20-018956.hdr.sgml : 20200710 20200710212157 ACCESSION NUMBER: 0000899243-20-018956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200708 FILED AS OF DATE: 20200710 DATE AS OF CHANGE: 20200710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ignelzi Troy A. CENTRAL INDEX KEY: 0001579829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 201024177 MAIL ADDRESS: STREET 1: C/O ESPERION THERAPEUTICS, INC. STREET 2: 46701 COMMERCE CENTER DRIVE CITY: PLYMOUTH STATE: MI ZIP: 48170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-08 0 0001771917 Karuna Therapeutics, Inc. KRTX 0001579829 Ignelzi Troy A. C/O KARUNA THERAPEUTICS, INC. 33 ARCH ST STE 3110 BOSTON MA 02110-1424 0 1 0 0 Chief Financial Officer Common Stock 2020-07-08 4 M 0 6000 9.20 A 6000 D Common Stock 2020-07-08 4 M 0 2000 9.20 A 8000 D Common Stock 2020-07-08 4 S 0 6000 98.32 D 2000 D Common Stock 2020-07-08 4 S 0 2000 100.00 D 0 D Option (right to buy) 9.20 2020-07-08 4 M 0 6000 0.00 D 2020-03-01 2029-03-21 Common Stock 6000 244794 D Option (right to buy) 9.20 2020-07-08 4 M 0 2000 0.00 D 2020-03-01 2029-03-21 Common Stock 2000 242794 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Troy Ignelzi 2020-07-10